Search

Mirati Therapeutics Inc

Gesloten

SectorGezondheidszorg

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-0.05% downside

Nieuwssentiment

By Acuity

50%

50%

129 / 339 Rangschikking in Healthcare

Mirati Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 sep 2026, 23:56 UTC

News

Lululemon Athletica shares are lower in after-market hours amid an investigation into potential securities law violations following a revenue guidance cut.

15 sep 2026, 23:41 UTC

Correlated Moves
News

Heartland Express shares are lower in after-market trading, influenced by declines in Schneider National and concerns from the New York Empire State Manufacturing Index.

15 sep 2026, 23:41 UTC

Correlated Moves
News

Tower Semiconductor shares are lower in after-market hours amid broader market dynamics and rising treasury yields ahead of the Federal Reserve's policy decision.

15 sep 2026, 23:31 UTC

News

Xylem Inc. shares declined in after-market hours following a $1.5 billion senior notes offering, reflecting broader market trends and shifting investor sentiment.

15 sep 2026, 23:26 UTC

News

Phil Poliquin has been appointed senior vice president at United Bankshares, focusing on government contracting. Shares are roughly flat in after-market trading.

15 sep 2026, 23:16 UTC

News

FedEx shares are lower in after-market trading following the appointment of Mike Rodgers as Chief Commercial and Technology Officer amid broader market pressure.

15 sep 2026, 23:16 UTC

News

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

15 sep 2026, 23:11 UTC

News

Coca-Cola Europacific Partners PLC gains in after-market hours on a planned $10 billion investment in U.S. infrastructure through 2030, focusing on production and distribution.

15 sep 2026, 23:06 UTC

News

FuelCell Energy shares rise in after-hours trading following insider purchases. Director John Livingston bought 26.3K shares for $247K on September 14.

15 sep 2026, 23:06 UTC

News

Apple Inc. shares rose in after-market trading following a product event that introduced new offerings and received an "Overweight" rating from Morgan Stanley with a $360 target.

15 sep 2026, 23:06 UTC

Correlated Moves
News

Blackstone Inc's shares are higher in after-market trading, likely influenced by KKR & Co Inc's recovery and recent IPO activity highlighted by CFO Michael Chae.

15 sep 2026, 23:06 UTC

News

UnitedHealth Group will release third quarter 2026 results on October 13. Shares are trading higher in after-market hours, reflecting a modest gain.

15 sep 2026, 23:06 UTC

News

Intuit Inc reported full-year revenue of $21.4 billion, a 14% increase. Shares are higher in after-market trading following the results and positive sentiment.

15 sep 2026, 23:02 UTC

News

Walmart shares rose in after-market trading following a 5.1% growth in global enterprise, surpassing its average target and reflecting strong consumer spending.

15 sep 2026, 23:02 UTC

News

Permian Resources shares are higher in after-market trading, with a current price of $24.49, reflecting strong long-term performance and a market cap of $20.51 billion.

15 sep 2026, 23:02 UTC

News
Social Media

RTX shares are higher in after-market trading following the appointment of Jill Albertelli as president of Pratt & Whitney, effective January 1, 2027.

15 sep 2026, 23:02 UTC

Correlated Moves
News

Chevron Corp shares are lower in after-market hours, influenced by a drop in the New York Empire State Manufacturing Index and ongoing supply risks.

15 sep 2026, 23:02 UTC

News
Event

Trip.com Group Ltd reported second-quarter EPS of $1.07, exceeding expectations, while shares rose in after-market trading following the earnings announcement.

15 sep 2026, 23:02 UTC

News

Target Corp shares are trading higher in after-market hours following the announcement of a new employee apparel line designed by Isaac Mizrahi.

15 sep 2026, 23:02 UTC

Social Media
News

Celsius Holdings Inc. shares rose in after-hours trading following significant insider purchases totaling around $1 million by Director Damon DeSantis.

15 sep 2026, 23:02 UTC

Correlated Moves
News

Qualcomm's after-market trading remains stable, reflecting Nasdaq 100 trends. The company reported $9.9 billion in revenue for the fiscal third quarter.

15 sep 2026, 23:02 UTC

News

CrowdStrike Holdings shares are lower in after-market hours amid negative sentiment following a sharp decline in the New York Empire State Manufacturing Index.

15 sep 2026, 23:02 UTC

News

Radiant Logistics shares are higher in after-market trading despite Glencore's $2 billion lawsuit alleging fraud and terminating business relationships with Radiant World.

15 sep 2026, 23:02 UTC

Correlated Moves
News

Coinbase Global shares are lower in after-hours trading, influenced by declines in Bitcoin and Bitmine Immersion Technologies, amid a weak overall trading environment.

15 sep 2026, 23:01 UTC

News

Boeing's recent Pentagon agreements include a $13.4 billion expansion of the KC-46 contract, though shares traded roughly flat in after-market hours.

15 sep 2026, 23:01 UTC

News
Event

Evolution Petroleum shares are higher after reporting fourth-quarter revenue of $24.21 million, exceeding expectations, though adjusted EPS missed consensus estimates.

15 sep 2026, 23:01 UTC

News

Interactive Brokers Group has integrated with X Cashtags, enabling US users to trade directly from tagged stock and crypto symbols. Shares are higher in after-market hours.

15 sep 2026, 23:01 UTC

News

D.R. Horton announced a $5 billion stock repurchase program and raised its fiscal 2026 buyback target to $3.25 billion, contributing to after-market gains.

15 sep 2026, 23:01 UTC

News

Alignment Healthcare Inc. shares are lower in after-market hours as bipartisan lawmakers introduce the Protecting Approved Care Act, impacting Medicare Advantage plans.

15 sep 2026, 23:01 UTC

News

Coca-Cola Co plans a $10 billion investment in U.S. infrastructure by 2030. Shares showed little change during after-market hours, reflecting stable trading conditions.

Peer Vergelijking

Prijswijziging

Mirati Therapeutics Inc Prognose

Koersdoel

By TipRanks

-0.05% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 58.67 USD  -0.05%

Hoogste 59 USD

Laagste 58 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Mirati Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

0

Buy

5

Hold

0

Sell

Sentiment

By Acuity

129 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

$

Over Mirati Therapeutics Inc

Mirati Therapeutics, Inc. is a clinical-stage oncology company. It is focused on developing therapeutics to address the genetic and immunological promoters of cancer. Its clinical programs consist of product candidates, including Adagrasib (MRTX849), MRTX1133, and Sitravatinib. MRTX849 is an oral small-molecule therapy designed to shrink difficult-to-treat cancers harboring the KRAS G12C mutation. MRTX1133 is a small molecule-inhibitor of the KRASG12D mutation, designed to treat patients with unmet need. Sitravatinib is a spectrum-selective receptor tyrosine kinase (RTK) inhibitor that can stimulate the body’s immune response to fight cancer. MRTX849 is in Phase III and Phase I/II clinical trials and MRTX1133 is in preclinical development. Sitravatinib is in a Phase III clinical trial, and Phase I/II clinical trials. It also has additional preclinical discovery programs, which includes first-in-class and best-in-class product candidates designed to address mutations and tumors.
help-icon Live chat